FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

Heart-Valve, Non-Allograft Tissue

PMA: P170006 · Supplement: S027 · Decision Sep 25, 2023
Classifications
1
FEI Numbers
19
Registration Numbers
19

Basic Information

Device Name
Heart-Valve, Non-Allograft Tissue
Trade Name
Avalus™ Bioprosthesis
PMA Number
P170006
Supplement Number
S027
Device Class
FDA Class 3
Product Code
LWR
Generic Name
heart-valve, non-allograft tissue
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
30-Day Notice Accepted
Decision Code
OK30
Decision Date
September 25, 2023
Date Received
September 12, 2023
Supplement Type
30-Day Notice
Supplement Reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

New sterilization cycle for moist heat sterilization of the primary packaging for the Evolut R, PRO, PRO+, FX Transcatheter Aortic Valves (TAV), the Harmony and Melody Transcatheter Pulmonary Valves (TPV), and the Avalus Bioprosthesis manufactured in Tijuana, Mexico. Additionally, a new sterilization configuration for the primary packaging sterilization is also being introduced for the Evolut TAV jars and Harmony TPV jars.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
LWR Heart-Valve, Non-Allograft Tissue